Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Type 2 Diabetes Age: Adult |
Dose: Tablet – 1 tablet (4 mg / 1 mg) Frequency: once daily Note: Administer with first meal of day. Titrate: glimepiride component increased not to exceed 2 mg every 1-2 weeks. Not to exceed 8 mg rosiglitazone / 4 mg glimepiride. |
|
Indication: Type 2 Diabetes Age: Geriatric |
Dose: Tablet – 1 tablet (4 mg / 1 mg) Frequency: once daily Note: Administer with first meal of day. Titrate dose carefully. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: Not recommended |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Tablet – 4 mg/1 mg Frequency: once daily Note: Starting dose: 1 tablet with first meal of day; titrate carefully |
Administration
- Take with first main meal
- Take at same time each day
Side Effect
- Edema (3%)
- Myocardial infarction (Less than 3%)
- Cerebrovascular accident (Less than 2%)
- Cardiac failure (Less than 3%)
- Headache (3-6%)
- Hypoglycemia (4-6%)
- Bone fracture (Less than 8%)
- Nasopharyngitis (4-5%)
- Weight gain
- Cardiac failure
- Increased serum ALT
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Salicylates, Sulfonamides, Chloramphenicol, Clarithromycin, Coumarin Anticoagulants (Warfarin, Heparin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban), Probenecid, CYP2C9 inhibitors, Fibric acid derivatives, Disopyramide, Fluoxetine, Quinolones, ACE Inhibitors (Captopril, Enalapril, Lisinopril, Ramipril, Benazepril, Fosinopril, Quinapril, Perindopril), MAOIs (Phenelzine, Tranylcypromine, Selegiline, Moclobemide), β-blockers
|
May potentiate hypoglycaemic action of glimepiride
|
|
Thiazides, Other diuretics, Corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Hydrocortisone), Phenothiazines, Thyroid products, Oestrogens, Phenytoin, Nicotinic acid, Sympathomimetics (Ephedrine, Pseudoephedrine, Phenylephrine), CYP2C9 inducers
|
May reduce hypoglycaemic effect of glimepiride
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Class III or IV Heart Failure
|
Can worsen heart failure
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.